1573. Viral Blips While on Antiretroviral Therapy are Associated with Virologic Failure

Madeline Fleit(Walter Reed National Military Medical Center), Anuradha Ganesan, Tahaniyat Lalani(Henry M. Jackson Foundation), Catherine M Berjohn(Henry M. Jackson Foundation), Christina Schofield(Madigan Army Medical Center), Xiuping Chu(Henry M. Jackson Foundation), Joseph Yabes(Brooke Army Medical Center), Rhonda E Colombo(Henry M. Jackson Foundation), Trevor A. Crowell(Henry M. Jackson Foundation), Christie Joya, Jason M Blaylock, Brian K. Agan(Henry M. Jackson Foundation), Hsing-Chuan Hsieh(Henry M. Jackson Foundation), Evan Ewers(Alexander T. Augusta Military Medical Center)
Open Forum Infectious Diseases
November 27, 2023
10.1093/ofid/ofad500.1408
Cited by 0

Related Papers

Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
|The Lancet|2017|196
Infection-Associated Clinical Outcomes in Hospitalized Medical Evacuees After Traumatic Injury: Trauma Infectious Disease Outcome Study
|The Journal of Trauma: Injury, Infection, and Critical Care|2011|137
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
|Science Translational Medicine|2022|94
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study
|The Lancet HIV|2020|91